Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer/Neurocrine File First Indiplon NDA With Eye On Q4 2005 Launch

Oct 25 2004

• By The Pink Sheet

Related Content

Pfizer’s Eye-Openers: Company Licenses Insomnia, Blindness Agents

Dec 23 2002

Merck Adds To Phase III Pipeline With Lundbeck Sleep-Aid Gaboxadol

Feb 16 2004

No Rest For Sonata: King To Develop XR Version After Acquisition From Elan

Feb 03 2003

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window